Ahead of this year's Nobel Prize announcements, STAT chatted with Mary-Claire King, who discovered the BRCA cancer mutations ...

Congo's Ebola outbreak has killed more than 4,000 people, authorities said, as they struggle to contain what has become the ...

News of a fifth measles death in Pennsylvania underscores a longstanding issue about the disease. The full scope of the ...

Lizzy led STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.

Proposed changes to the federal government’s health survey would undercount Americans with disabilities, advocates say.

The U.S. approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of ...

Senate committees that handle important health care matters are about to see major GOP turnover. Here's what that means.

Premiums are stable, but Medicare Advantage plans are making big changes that could make care more expensive for patients.

The NIH continued reducing grants involving health disparities, race, and ethnicity but made little progress toward other administration priorities in the 2026 fiscal year.

The gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used it to ...

Why have so many Americans lost trust in science? And what's the deal with a new gene-editing lawsuit? Find out on this ...